China Dasheng Biotechnology Company 

$0.1
7
+$0.06+140.38% Wednesday 00:00

Statistics

Day High
0.06
Day Low
0.06
52W High
0.15
52W Low
0
Volume
10,000
Avg. Volume
2,890
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q4 2007
Q1 2008
Q2 2008
Q3 2008
Q4 2008
0.01
0.06
0.1
0.14
Expected EPS
N/A
Actual EPS
0.0435

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDBT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited is involved in discovering, developing, and commercializing a broad range of healthcare and pharmaceutical products, overlapping with CDBT's market in biotechnological healthcare solutions.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the biotech sector focused on healthcare and medical treatments.
Wuxi AppTec.
WUXAY
Mkt Cap41.71B
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech, and medical device industries to advance discoveries and deliver groundbreaking treatments, directly competing with CDBT's services.
Can-Fite Biopharma
CANF
Mkt Cap15.35M
Can-Fite BioPharma Ltd. is a biotechnology company developing drugs with an emphasis on cancer, making it a competitor in the biotech industry focused on innovative treatments.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, especially for women's health, competing with CDBT in the broader healthcare and biotech market.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, competing in the biotech and healthcare sector.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is one of the world's leading biotechnology companies, focusing on areas such as cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation, competing across several of CDBT's operational areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical corporation which develops and produces medicines and vaccines for a wide range of medical disciplines, including those covered by CDBT's biotechnological research and development.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. focuses on mRNA-based therapeutics and vaccines, competing in the innovative biotech sector where CDBT also aims to make its mark with biotechnological advancements and healthcare solutions.

About

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company is based in Lanzhou, China.
Show more...
CEO
Mr. Jinjun Qi
Employees
689
Country
US
ISIN
US16944C1080

Listings

0 Comments

Share your thoughts

FAQ

What is China Dasheng Biotechnology Company stock price today?
The current price of CDBT is $0.1 USD — it has increased by +140.38% in the past 24 hours. Watch China Dasheng Biotechnology Company stock price performance more closely on the chart.
What is China Dasheng Biotechnology Company stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange China Dasheng Biotechnology Company stocks are traded under the ticker CDBT.
Is China Dasheng Biotechnology Company stock price growing?
CDBT stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year China Dasheng Biotechnology Company has showed a -28.14% decrease.
What were China Dasheng Biotechnology Company earnings last quarter?
CDBT earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does China Dasheng Biotechnology Company have?
As of April 01, 2026, the company has 689 employees.
In which sector is China Dasheng Biotechnology Company located?
China Dasheng Biotechnology Company operates in the Financials sector.
When did China Dasheng Biotechnology Company complete a stock split?
China Dasheng Biotechnology Company has not had any recent stock splits.
Where is China Dasheng Biotechnology Company headquartered?
China Dasheng Biotechnology Company is headquartered in Lanzhou, US.